Systemic lupus erythematosus is the prototypic multi-system autoimmune disease characterized by the production of multiple autoantibodies. The development of disease depends on a genetic predisposition and exposure to environmental factors including UV light, drugs, and infections. The association of parasitic infection and the development of autoimmune disease in general and lupus in particular remains elusive. In this paper, we review the recent evidence for protection from autoimmunity by parasites, models of parasite-related autoimmunity, molecular mimicry, the impact of parasitic molecules on the immune response and the association between parasitic load and the degree of autoimmunity.
Sherer Y., Gorstein A., Fritzler MJ, Shoenfeld Y.Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum2004; 34: 501-537.
2.
Shoenfeld Y. , Zandman-Goddard G., Stojanovich L., et al. The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases -2008. Israel Med Assoc J2008; 10: 8-12.
3.
Zandman-Goddard G., Shoenfeld Y.Infections and SLE. Autoimmunity2005; 38: 473-485.
4.
Zandman-Goddard G., Berkun Y., Barzilai O., et al. Exposure to Epstein-Barr virus infection is associated with mild SLE disease. Ann NY Acad Sci2009; in press.
5.
Zandman-Goddard G., Berkun Y., Barzilai O., et al. Neuropsychiatric lupus and infectious triggers. Lupus2008; 17: 380-384.
6.
Ram M., Shoenfeld Y.Hepatitis B: Infection, vaccination and hepatitis B surface antigen. IMAJ2008; 10: 61-64.
7.
van Riet E., Hartgers FC, Yazdanbakhsh M.Chronic helminth infections induce immunomodulation: consequences and mechanisms . Immunobiology2007; 212: 475-490.
8.
Finkelman FD , Shea-Donohue T., Morris SC, et al. Interleukin-4 and interleukin 13-mediated host protection against intestinal nematode parasites. Immunol Rev2004; 201: 139-155.
9.
Cervi L., MacDonald AS, Kane C., Dzierszinki F., Pearce EJCutting edge: dendritic cells copulsed with microbial and helminth antigens undergo modified maturation, segregate the antigens to distinct intracellular compartments, and concurrently induce microbe-specific Th1 and helminth-specific Th2 responses. J Immunol2004; 172: 2016-2020.
10.
Balic A., Harcus Y., Hooland MJ, Maizels RMSelective maturation of dendritic cells by Nippostrogylus brasiliensis-secreted proteins drives Th2 immune responses. Eur J Immunol2004; 34: 3047-3059.
11.
Thomas PG, Carter MR, Atochina O., et al. Maturation of dendritic cell 2 phenotype by a helminth glycan uses a toll-like receptor 4-dependent mechanism. J Immunol2003; 171: 5837-5841.
12.
Whelan M., Harnett MM, Houston KM, Patel V., Harnett W., Rigley KPA filarial nematode-secreted product signals dendritic cells to acquire a phenotype that drives development of Th2 cells. J Immunol2000; 164: 6453-6460.
13.
Kane CM, Cervi L., Sun J., et al. Helminth antigens modulate TLRinitiated dendritic cell activation . J Immunol2004; 173: 7454-7461.
van der Kleij D., Latz E., Brouwers JF, et al. A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates Toll-like receptor 2 and affects immune polarization. J Biol Chem2002; 277: 48122-48129.
16.
Askoy E., Zouain CS, Vanhoutte F., et al. Double stranded RNAs from the helminth parasite Schistosoma activate TLR3 in dendritic cells. J Biol Chem2005; 280: 277-283.
17.
Goodridge HS , Marshall FA, Else KJ, et al. Immunomodulation via novel use of TLR4 by the filarial nematode phosporylcholinecontaining secreted product, ES-62. J Immunol2005; 174: 284-293.
18.
Abu-Shakra M., Shoenfeld Y.Parasitic infection and autoimmunity. In: Shoenfeld Y, Rose N (eds), Infection and autoimmunity. Amsterdam: Elsevier; 2004. p. 439-448.
19.
Zandman-Goddard G., Chapman J., Shoenfeld Y.Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin Arthritis Rheum2007; 36: 297-315.
20.
Levitus G., Hontebeyrie-Joskowicz M., Van-Regenmortel MH, Levin MJHumoral autoimmune response to ribosomal P proteins in demonstrated in chronic Chagas heart disease. Clin Exp Immunol1991 ; 85: 413-417.
21.
Perone D., santos MA, Peixoto MS, Cicarelli RMTrypanosoma cruzi: identification and characterization of a novel ribosomal protein L27 (TcrL27) that cross-reacts with an affinity-purified anti-Sm antibody . Parasitology2003; 126: 577-583.
22.
Cooke A., Tonks P., Jones FM, et al. Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol1999; 21: 169-176.
23.
Zaccone P., Fehervari Z., Jones FM, et al. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type I diabetes. Eur J Immunol2003; 33: 1439-1449.
24.
Moreels TG, Nieuwendijk RJ, De Man JG, et al. Concurrent infection with Schistosoma mansoni attenuates inflammation induced changes in colonic morphology, cytokine levels, and smooth muscle contractility of trinitrobenzene sulphonic acid induced colitis in rats. Gut2004; 53: 99-107.
25.
Khan WI, Blennerhasset PA, Varghese AK, et al. Intestinal nematode infection ameliorates experimental colitis in mice. Infect Immunol2002; 70: 5931-5937.
26.
Summers RW, Elliot DE, Urban JF Jr, Thompson RA, Weinstock JVTrichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology2005; 128: 825-832.
27.
Sewell D., Qing Z., Reinke E., et al. Immunomodulation of experimental allergic encephalitis by helminth ova immunization. Int Immunol2003; 15: 59-69.
28.
Diaz A., Allen JEMapping immune response profiles: the emerging scenario from helminth immunology . Eur J Immunol2007; 37: 3319-3326.
29.
Hyland KV, Leon JS, Daniels MD, et al. Modulation of autoimmunity by treatment of an infectious disease . Infection Immun2007; 75: 3641-3650.
30.
La Flamme AC , Ruddenklau K., Backstrom BTSchistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalitis. Infect Immun2003; 71: 4996-5004.
31.
Berkun Y., Zandman-Goddard G., Barzilai O., et al. Infectious antibodies in systemic lupus erythematosus patients . Lupus2009; this issue.
32.
Chen M., Aosai F., Norose K., et al. Toxoplasma gondii infection inhibits the development of lupus-like syndrome in autoimmune (New Zealand black X New Zealand white) F1 mice. Int Immunol2004; 16: 937-946.
33.
Clatworthy MR, Willcocks L., Urban B., et al. Systemic lupus erythematosus-associated defects in the inhibitory receptor FcgammaRIIb reduce susceptibility to malaria . Proc Natl Acad Sci USA2007; 104: 7169-7174.
